The association between polyvascular disease and cardiovascular outcomes in patients with type 2 diabetes: a SUB-analysis of empa-REG outcome
Abstract
Polyvascular disease increases the risk for atherosclerotic cardiovascular (CV) events, but this is not well investigated in people with type 2 diabetes (T2D). Moreover, as it is unknown whether the number of vascular beds (VBs) involved is a risk marker also for hospitalization for heart failure (
Read the paper
Related studies
- Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa
- Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis
- A methodology for assessing deployment trauma and its consequences in OEF/OIF/OND veterans: The TRACTS longitudinal prospective cohort study
- Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study
- Factors Influencing Primary and Secondary Implant Stability—A Retrospective Cohort Study with 582 Implants in 272 Patients
- Electroacupuncture for Painful Diabetic Peripheral Neuropathy: A Multicenter, Randomized, Assessor-Blinded, Controlled Trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.